期刊文献+

2014年改变乳腺癌临床实践的研究进展 被引量:1

2014 Research Advance in Alerting Breast Cancer Clinical Practice
下载PDF
导出
摘要 2014年,乳腺癌的治疗取得巨大进步,局部和全身复发率都显著降低了,这得益于高质量的多学科协作团队,以及多年来一些重要的改变临床实践的研究结果。Cossetti等[1]2014年在JCO上发表的一篇文章,是对英属哥伦比亚地区的人群学研究,探讨1986-1992年和2004-2008年间不同亚型乳腺癌复发风险的差异。数据显示,无论任何亚型,
作者 廖宁
出处 《循证医学》 CSCD 2015年第1期8-10,13,共4页 The Journal of Evidence-Based Medicine
关键词 乳腺癌 研究进展 临床试验 breast cancer research advances clinical trials
  • 相关文献

参考文献19

  • 1Cossetti RJD, Tyldesley SK, Speers CH, et al. Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008 [J]. J Clin Oncol, 2015, 33(1) :65-73. 被引量:1
  • 2Tolaney SM, Barry WT, Dang CT et al. Adjuvant paelitaxel and Trastuzumab for node-negative, HER2-positive breast cancer[J]. N Engl J Med, 2015,372(2):134-141. 被引量:1
  • 3Francis PA, Regan MM, Fleming GF, et al. Adjuvant ovarian suppression in premenopansal breast cancer[J]. N Engl J Med, 2014, Dec 11. [Epnb ahead of print] doi: 10.1056/NEJMoa 1412379. 被引量:1
  • 4Houssami N1, Macaskill P, Marinovich ML, et al. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast- conserving therapy: A meta-analysis [J]. Ann Surg Oncol,2014, 21(3): 717-730. 被引量:1
  • 5Moran MS, Sehnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on margins for breast-conserving surgery with whole- breast irradiation in stages I and II invasive breast cancer[J]. J Clin Oncol, 2014, 32(14) : 1507-1515. 被引量:1
  • 6Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on margins for breast-conserving surgery with whole- breast irradiation in stages I and II invasive breast cancer[J]. Int J Radiat Oncol Biol Phys, 2014, 88(3) :553-564. 被引量:1
  • 7Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on margins for breast-conserving surgery with whole- breast irradiation in stages I and lI invasive breast cancer[J]. Ann Surg Oncol, 2014, 21(3):704-716. 被引量:1
  • 8Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis[J]. Lancet, 2014, 384(9938) : 164- 172. 被引量:1
  • 9Berruti A, Amoroso V, Gallo F, et al. Pathologic eomplete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: A meta- regression of 29 randomized prospective studies [J]. J Clin Oncol, 2014, 32(34): 3883-3891. 被引量:1
  • 10Miller KD, Di6ras V, Harbeck N, et al. Phase ]I a trial of Trastuzumab Emtansine with Pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer[J]. J Clin Oncol, 2014, 32(14) : 1437-144-4. 被引量:1

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部